Total Payments
$22,171
2024 Payments
$11,228
Companies
36
Transactions
675
Medicare Patients
9,645
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$12,220 (55.1%)
Consulting$8,208 (37.0%)
Travel$1,510 (6.8%)
Education$233.47 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,220 | 665 | 55.1% |
| Consulting Fee | $8,208 | 1 | 37.0% |
| Travel and Lodging | $1,510 | 4 | 6.8% |
| Education | $233.47 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ConvaTec Inc. | $10,367 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $1,863 | 113 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,207 | 77 | $0 (2024) |
| ABBVIE INC. | $1,005 | 68 | $0 (2024) |
| ViiV Healthcare Company | $976.10 | 72 | $0 (2022) |
| Insmed, Inc. | $923.36 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $772.00 | 32 | $0 (2024) |
| Allergan, Inc. | $578.56 | 51 | $0 (2020) |
| Cumberland Pharmaceuticals, Inc. | $575.56 | 13 | $0 (2022) |
| La Jolla Pharmaceutical Company | $526.50 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,228 | 60 | ConvaTec Inc. ($10,309) |
| 2023 | $1,500 | 71 | Gilead Sciences, Inc. ($295.46) |
| 2022 | $1,909 | 80 | Cumberland Pharmaceuticals, Inc. ($439.42) |
| 2021 | $1,579 | 109 | Gilead Sciences, Inc. ($354.58) |
| 2020 | $1,658 | 103 | Insmed, Inc. ($263.22) |
| 2019 | $2,635 | 142 | CIPLA USA INC. ($495.43) |
| 2018 | $1,092 | 79 | ViiV Healthcare Company ($259.12) |
| 2017 | $568.53 | 31 | Theratechnologies Inc. ($103.66) |
All Payment Transactions
675 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/18/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Consulting Fee | Cash or cash equivalent | $8,207.50 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 12/18/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Travel and Lodging | Cash or cash equivalent | $429.95 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 12/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/02/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 11/25/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.88 | General |
| 10/22/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.73 | General |
| 10/03/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.06 | General |
| 09/09/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Travel and Lodging | Cash or cash equivalent | $546.44 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Travel and Lodging | Cash or cash equivalent | $266.70 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $135.03 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $120.94 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $86.94 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ADVANCED WOUND CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,733 | 3,699 | $589,409 | $234,196 |
| 2022 | 15 | 1,085 | 2,301 | $452,231 | $172,044 |
| 2021 | 24 | 2,265 | 4,520 | $881,710 | $347,499 |
| 2020 | 38 | 4,562 | 13,136 | $2.2M | $1.0M |
Total Patients
9,645
Total Services
23,656
Medicare Billing
$1.8M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 302 | 867 | $173,400 | $75,871 | 43.8% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 140 | 607 | $100,155 | $43,702 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 315 | 336 | $131,040 | $42,927 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 245 | 460 | $64,400 | $26,684 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 226 | $46,330 | $20,865 | 45.0% |
| 29581 | Application of vein wound compression bandages on lower leg, ankle, and foot | Office | 2023 | 27 | 66 | $16,665 | $5,465 | 32.8% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 55 | 201 | $12,060 | $4,052 | 33.6% |
| 97598 | Removal of tissue from wound, each additional 20.0 sq cm | Office | 2023 | 24 | 128 | $12,800 | $4,005 | 31.3% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 40 | 40 | $8,000 | $3,010 | 37.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 87 | 160 | $5,760 | $1,646 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $3,360 | $1,527 | 45.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 82 | 155 | $5,115 | $1,172 | 22.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $3,180 | $1,160 | 36.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 109 | $2,180 | $915.60 | 42.0% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 83 | 157 | $3,454 | $797.56 | 23.1% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 80 | 151 | $1,510 | $400.15 | 26.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 324 | 1,115 | $223,000 | $85,082 | 38.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 268 | 293 | $114,270 | $43,078 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 263 | 563 | $78,820 | $29,689 | 37.7% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 65 | 97 | $16,005 | $6,838 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 22 | $4,510 | $2,106 | 46.7% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2022 | 17 | 17 | $3,400 | $1,283 | 37.7% |
| 97598 | Removal of tissue from wound, each additional 20.0 sq cm | Office | 2022 | 15 | 41 | $4,100 | $1,272 | 31.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,915 | $1,054 | 36.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 17 | 17 | $1,564 | $666.68 | 42.6% |
About Dr. Imad Omer, M.D
Dr. Imad Omer, M.D is a Infectious Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356318059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imad Omer, M.D has received a total of $22,171 in payments from pharmaceutical and medical device companies, with $11,228 received in 2024. These payments were reported across 675 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,220).
As a Medicare-enrolled provider, Omer has provided services to 9,645 Medicare beneficiaries, totaling 23,656 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Memphis, TN
- Active Since 03/02/2006
- Last Updated 01/03/2019
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1356318059
Products in Payments
- INNOVAMATRIX AC (Device) $10,594
- AVYCAZ (Drug) $1,229
- Arikayce (Drug) $803.56
- XERAVA (Drug) $583.64
- VIBATIV (Drug) $563.43
- DOVATO (Drug) $514.77
- ZEMDRI (PLAZOMICIN) (Drug) $495.43
- Cresemba (Drug) $445.61
- DIFICID (Drug) $347.51
- ISENTRESS (Drug) $339.41
- EGRIFTA (Drug) $295.00
- DALVANCE (Drug) $247.35
- ZERBAXA (Drug) $236.22
- PIFELTRO (Drug) $226.25
- JULUCA (Drug) $173.92
- Xerava (Drug) $170.76
- DORYX (Drug) $156.42
- Fetroja (Drug) $155.48
- TROGARZO (Drug) $151.21
- SYMTUZA (Drug) $136.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Memphis
Dr. Michael Gelfand, Md, MD
Infectious Disease — Payments: $847,459
Infectious Disease $847,459
Dr. Kerry Cleveland, Md, MD
Infectious Disease — Payments: $679,099
Infectious Disease $679,099
Stephen Threlkeld, M.d, M.D
Infectious Disease — Payments: $28,820
Infectious Disease $28,820
Margarita Lamothe, M.d, M.D
Infectious Disease — Payments: $13,658
Infectious Disease $13,658
Dr. James Dale, Md, MD
Infectious Disease — Payments: $8,250
Infectious Disease $8,250
Michael Threlkeld, M.d, M.D
Infectious Disease — Payments: $4,437
Infectious Disease $4,437